Rabetac, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Acidity. Rabetac also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Rabetac. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The most common side effects of Rabetac are Diarrhoea. Besides the aforementioned side effects, there are other adverse effects of Rabetac as well, which are listed below. Usually, these side effects of Rabetac go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Rabetac's effect during pregnancy is Safe and Moderate while nursing. Warnings related to Rabetac's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Diarrhea (Loose Motions) must refrain from the use of Rabetac since this can cause severe adverse effects. Some other conditions that can be affected by Rabetac are listed in the contraindications section below.
Drug interactions for Rabetac have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Rabetac is considered not safe while driving, and is not addictive.
Rabetac is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Rabetac safe for pregnant women?
Pregnant women can take Rabetac without worrying about any side effects.
Is the use of Rabetac safe during breastfeeding?
Rabetac may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Rabetac, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Rabetac.
What is the effect of Rabetac on the Kidneys?
Rabetac is completely safe for kidneys.
What is the effect of Rabetac on the Liver?
Rabetac may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Rabetac on the Heart?
You can take Rabetac without any fear of damage to the heart.
Rabetac should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rabetac unless your doctor advises you to do so -
Is this Rabetac habit forming or addictive?
Forming a habit of Rabetac has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Rabetac as you may feel sleepy.
Is it safe?
Yes, Rabetac is safe for use.
Is it able to treat mental disorders?
No, the use of Rabetac in mental disorders is not effective.
Interaction between Food and Rabetac
Taking Rabetac with food does not cause any problems.
Interaction between Alcohol and Rabetac
Consumption of alcohol and Rabetac together may have severe effects on your health.
No, Rabetac does not cause kidney damage at recommended doses. However, in case of long-term use of Rabetac along with improper kidney function, might cause kidney damage. If you experience discoloration of urine ( symptoms of kidney damage) then immediately inform to doctor and follow his/her instructions.
Yes, Rabetac might lead to low magnesium levels in persons who take it for at least 3 months. Magnesium helps in absorption of vitamin D and calcium, low level of magnesium will affect the absorption of Vit. D and calcium lead to decrease bone density and increases the risk of bone fracture. Low-level magnesium can be managed by taking a dietary supplement which is rich in magnesium.
Rabetac is a brand name for rabeprazole. It belongs to a class of medications known as proton pump inhibitors. It is available in the form of a tablet, capsule, and injection. Rabetac is used to alleviate the symptoms of gastroesophageal reflux disorder (GERD). GERD is a condition in which acid back-flows from the stomach to the esophagus (the tube which connects the stomach with throat) causing heartburn and injury to the esophagus. Rabetac is used to prevent this damage. Rabetac is also used to treat conditions like Zollinger Ellison syndrome (excessive acid is produced by the stomach). It is used for the treatment of ulcers (sores in the lining of stomach and intestine) and also used in combination with other antibiotics (such as amoxicillin and clarithromycin) to manage H.pylori infection.
This is because a long-term use of Rabetac can cause Vitamin B12 deficiency. Stomach acids help in the absorption of Vitamin B 12, and this drug suppresses stomach acid which is required for the absorption of vitamin B12. Hence patients taking [medicine] for a long time have Vitamin B12 deficiency. To replenish Vitamin B12 in your body your doctor prescribes this vitamin along with this medicine.
No, Rabetac doesn't cause high blood pressure. High blood pressure can be managed by losing some amount of weight, doing some kind of physical activity on a daily basis, eating a healthy diet, reducing sodium in the diet, limiting the amount of alcohol and caffeine, quitting smoking, and taking less stress. If your blood pressure doesn't get controlled, your doctor might start you on a hypertensive drug ( amlodipine, telmisartan etc). Please follow the instructions of your doctor completely.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aciphex® (rabeprazole sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1077-1078
